Vanderbilt-Ingram Cancer Center is “pushing the envelope” with new technologies like histotripsy and new programs like robotic liver surgery and robotic pancreas surgery, serving patients not only from Tennessee, but also parts of Kentucky, Alabama and Georgia.  

Attendees gathered at Fat Bottom Brewing Company on May 20 for the event to raise awareness about the neurodegenerative disorder, amyotrophic lateral sclerosis (ALS).

The study is still recruiting participants. It will conclude in 2026 and provide insight for further investigations into the role GLP-1 agonists may offer in treating respiratory illnesses and overall immune responses.

The artificial intelligence model Enformer was retrained with tissue-specific datasets; this "transfer learning" approach outperformed the base model in identifying disease-associated genes.

The one-year professorship is administered by the American Association of Rhodes Scholars and is awarded annually to a senior scholar “of the highest distinction” from the United States.

Among numerous service lines at VML, the Histotechnology program prepares samples from surgeries, biopsies and autopsies.

The Vanderbilt Center for Antibody Therapeutics has received large-scale government grants and contracts to fund the discovery of human antiviral antibodies. The problem is the next step — finding corporate partners to develop the antibodies through human testing.